Willow Biosciences Inc. (CANSF)
CANSF Stock Price Chart
Explore Willow Biosciences Inc. interactive price chart. Choose custom timeframes to analyze CANSF price movements and trends.
CANSF Company Profile
Discover essential business fundamentals and corporate details for Willow Biosciences Inc. (CANSF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
8 Jan 2021
Employees
19.00
Website
https://www.willowbio.comCEO
Travis Doupe
Description
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.
CANSF Financial Timeline
Browse a chronological timeline of Willow Biosciences Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 23 Mar 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 28 Aug 2025
Earnings released on 12 May 2025
EPS came in at -$0.00 , while revenue for the quarter reached $1.24M .
Earnings released on 25 Mar 2025
EPS came in at -$0.00 , while revenue for the quarter reached $1.31M .
Earnings released on 12 Nov 2024
EPS came in at -$0.01 , while revenue for the quarter reached $1.25M .
Earnings released on 12 Aug 2024
EPS came in at -$0.01 , while revenue for the quarter reached $750.44K , beating expectations by +50.09%.
Earnings released on 13 May 2024
EPS came in at -$0.01 , while revenue for the quarter reached $37.56K , missing expectations by -92.49%.
Earnings released on 28 Mar 2024
EPS came in at -$0.01 , while revenue for the quarter reached $67.01K .
Earnings released on 14 Nov 2023
EPS came in at -$0.01 , while revenue for the quarter reached $497.60K , missing expectations by -0.48%.
Earnings released on 8 Aug 2023
EPS came in at -$0.02 , while revenue for the quarter reached $101.91K , missing expectations by -79.62%.
Earnings released on 12 May 2023
EPS came in at -$0.03 , while revenue for the quarter reached $202.49K , missing expectations by -59.50%.
Earnings released on 31 Dec 2022
EPS came in at -$0.03 , while revenue for the quarter reached $380.09K .
Earnings released on 3 Nov 2022
EPS came in at -$0.02 , while revenue for the quarter reached $35.78K , missing expectations by -92.84%.
Earnings released on 15 Aug 2022
EPS came in at -$0.02 , while revenue for the quarter reached $203.40K , missing expectations by -59.32%.
Earnings released on 12 May 2022
EPS came in at -$0.02 .
Earnings released on 29 Mar 2022
EPS came in at -$0.04 , while revenue for the quarter reached $7.06K , missing expectations by -97.77%.
Earnings released on 15 Nov 2021
EPS came in at $0.04 , while revenue for the quarter reached $93.58K , missing expectations by -81.28%.
Earnings released on 30 Sept 2021
EPS came in at $0.02 , while revenue for the quarter reached $1.58K .
Earnings released on 7 May 2021
EPS came in at -$0.08 , while revenue for the quarter reached $4.77K .
Earnings released on 23 Mar 2021
EPS came in at -$0.15 , while revenue for the quarter reached $5.98K .
Earnings released on 12 Nov 2020
EPS came in at -$0.07 , while revenue for the quarter reached $150.22 .
CANSF Stock Performance
Access detailed CANSF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.